• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Disruption of natural healing process in autoimmune myocarditis and progression to dilated cardiomyopathy

Research Project

Project/Area Number 12670653
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionNiigata University

Principal Investigator

HANAWA Haruo  University Medical Hospital, Niigata University, Assistant, 医学部・附属病院, 助手 (40282983)

Co-Investigator(Kenkyū-buntansha) KODAMA Makoto  Graduate School of Medical and Dental Sciences, Niigata University, Lecturer, 大学院・医歯学総合研究科, 講師 (10242447)
Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥3,200,000 (Direct Cost: ¥3,200,000)
Fiscal Year 2001: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2000: ¥1,900,000 (Direct Cost: ¥1,900,000)
Keywordsautoimmune myocarditis / gene therapy / gene expression / dilated cardiomyopathy / MCP-1 / IL-10 / endothelin / βblocker / オステオポンチン / 心筋炎 / 自己免疫疾患 / サイトカイン / ケモカイン
Research Abstract

(1) Marker in myocarditis
Elevation of sFas and sFasL levels at initial presentation appear to be a good serological marker to predict the prognosis of acute myocarditis. MCP-1 may play an important role in the pathogenesis of human acute myocarditis as well as in the progression of rat Experimental autoimmune myocarditis (EAM). Serum IL-10 levels may play a role m evaluation of the disease activity in patients with cardiac sarcoidosis.
(2) Therapy for myocarditis
A low dose of carvedilol has beneficial effects on rat dilated cardiomyopathy The area of myocardial fibrosis in chronic phase of Experimental autoimmune myocarditis was markedly reduced by quinapril. Bisoprolol improved survival independently, of its effect on left ventricular function by reducing sudden death in EAM. The prevention of EAM by administering the anti-CD 2 monoclonal antibody resulted from T cell depletion during theinduction phase,
(3) Gene therapy for EAM
Gene transfer into muscle by electroporation in vivo is an … More effective means of delivery of IL-10, INFγ receptor-IgG, secretary leukocyte protease inhibitor-IgG and CTLA4-IgG for the treatment of autoimmune myocarditis.
(4) Time Course of Gene Expression in EAM
α-cardiac myosin showed a 26-fold decrease and β-cardiac myosm a 3.9-fold increase at day 14. ANP and BNP increased 48- and 6.4-fold respectively at day 21 and 14. AT1 receptor, ACE and ET1 increased 22- at day 21, 6.3- at day 21 and 17-fold, respectively at day 14. Aldosterone receptor decreased 2.2-fold at day 14, but aldsterone synthethase was detected only at day 14 and 21. Interleukin (IL) -2, IL-10, interferon-γ and monocyte chemoattractant protein-1 increased 9.1- at day 14, 398- at day 21, 43- at day 14 and 142-fold at day 14, respectively. Collagen type 3, Collagen type 1 and fibronectin increased 35-, 1.7- and 45- fold at day 21. Interestingly, osteopontin showed a 4542-fold increase and it was the higtest mRNA of all at day 14.
Isoform of cardiac myosin and NP are dramatically changed in EAM. RAA and ET expressions are changed diversely in EAM time course. Cytokine, chemokine and ECM greatly increase and, especially, large numbers of osteopontin mRNA are expressed in early EAM. Less

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (26 results)

All Other

All Publications (26 results)

  • [Publications] Fuse, K.: "Enhanced expression and production of monocyte chemoattractant protein 1 in myocarditis"Clin Exp Immunol. 124. 346-352 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Fuse, K.: "Levels of serum interleukin-10 reflect disease activity in patients with cardiac sarcoidosis"Jpn Circ J. 64. 755-759 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Fuse, K.: "Predictors of disease course in patients with acute myocarditis"Circulation. 102. 2829-2835 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Ma, M.: "Inhibition of progression of heart failure and expression of TGF-betal mRNA in rats with heart failure by the ACE inhibitor quinapril"J Cardiovasc Pharmacol. 38. S51-S54 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Ohta, Y.: "Carvedilol enhances atrial and brain natriuretic peptide mRNA expression and release in rat heart"J Cardiovasc Pharmacol. 36. S19-S23 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Watanabe, K.: "Protection against autoimmune myocarditis by gene transfer of interleukin-10 by electroporation"Circulation. 104. 1098-1100 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Watanabe, K.: "Bisoprolol improves survival in rats with heart failure"J Cardiovasc Pharmacol. 38. S55-S58 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Watanabe, K.: "Acute effects of endothelin-1 and TAK-044 (ET(A) and ET(B) receptor antagonist) in rats with dilated cardiomyopathy"J Cardiovasc Pharmacol. 36. S49-S54 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Watanabe, K.: "Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyop"Br J Pharmacol. 130. 1489-1495 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Inomata, T.: "Anti-CD2 monoclonal antibodies prevent the induction of experimental autoimmune myocarditis"Jpn Heart J. 41. 507-517 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Fuse, K.: "Enhanced expression and production of monocyte chemoattractant protein-L in myocarditis"Clin Exp Immunol. 124. 346-52 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Fuse, K.: "Levels of serum interleukin-10 reflect disease activity in patients with cardiac sarcoidosis"Jpn Circ J. 64. 755-9 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Fuse, K.: "Predictors of disease course in patients with acute myocarditis"Circulation. 102. 2829-35 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Ma, M.: "Inhibition of progression of heart failure and expression of TGF-betal mRNA in rats with heart failure by the ACE inhibitor quinapril"J Cardiovasc Pharmacol. 38. S51-4 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Ohta, Y.: "Carvedilol enhances atrial and brain natriuretic peptide mRNA expression and release in rat heart"J Cardiovasc Pharmacol. 36. S19-23 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Watanabe, K.: "Protection against autoimmune myocarditis by gene transfer of interleukin-10 by electroporation"Circulation. 104. 1098-100 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Watahabe, K.: "Bisoprolol improves survival in rats with heart failure"J Cardiovasc Pharmacol. 38. S55-8 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Watanabe, K.: "Acute effects of endotheiin-1 and TAK-044 (ET(A) and ET(B) receptor antagonist) in rats with dilated cardiomyopathy"J Cardiovasc Pharmacol. 36. S49-54 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Watanabe, K.: "Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy"Br J Pharmacol. 130. 1489-95 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Inomata, T.: "Anti-CD2 monoclonal antibodies prevent the induction of experimental autoimmune myocarditis"Jpn Heart J. 41. 507-517 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Watanabe Kら: "Bisoprolol improves survival in rats with heart failure"J Cardiovasc Pharmacol. 38. S55-S58 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ma Mら: "Inhibition of progression of heart failure and expression of TGF-beta 1 mRNA in rats with heart failure by the ACE inhibitor quinapril"J Cardiovasc Pharmacol. 38. S51-S54 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Watanabe Kら: "Protection against autoimmune myocarditis by gene transfer of interleukin-10 by electroporation"Circulation. 104. 1098-1100 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Kodama Mら: "Changes in the occurrence of mechanical alternans after long-term beta-blocker therapy in patients with chronic heart failure"Jpn Circ J. 65. 711-716 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Kodama Mら: "Mechanical alternans in patients with chronic heart failure"J Card Fail. 7. 138-145 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Fuse K: "Enhanced Expression and Production of Monocyte Chemoattractant Protein-1 in Myocarditis"Clinical Experimental Immunology in press.

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi